Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
7.86
+0.02 (0.26%)
May 14, 2025, 2:53 PM - Market open
Regulus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 49.46 | 38.53 | 23.77 | 24.23 | 60.38 | 31.09 | Upgrade
|
| Short-Term Investments | 15.91 | 37.25 | - | 14.93 | - | - | Upgrade
|
| Cash & Short-Term Investments | 65.37 | 75.78 | 23.77 | 39.16 | 60.38 | 31.09 | Upgrade
|
| Cash Growth | -32.99% | 218.83% | -39.31% | -35.15% | 94.24% | -8.89% | Upgrade
|
| Receivables | - | - | - | - | - | 0.5 | Upgrade
|
| Inventory | 3.47 | 3.49 | 3.01 | 3.01 | 3.01 | 3.31 | Upgrade
|
| Prepaid Expenses | 2.79 | 3.02 | 1.34 | 1.85 | 1.78 | 1.83 | Upgrade
|
| Restricted Cash | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | - | Upgrade
|
| Total Current Assets | 71.69 | 82.35 | 28.18 | 44.08 | 65.24 | 36.73 | Upgrade
|
| Property, Plant & Equipment | 3.11 | 1.81 | 2.54 | 2.58 | 2.85 | 0.73 | Upgrade
|
| Other Intangible Assets | 0.02 | 0.03 | 0.03 | 0.06 | 0.08 | 0.13 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.29 | 0.02 | Upgrade
|
| Total Assets | 74.83 | 84.18 | 30.75 | 46.72 | 68.45 | 37.6 | Upgrade
|
| Accounts Payable | 0.2 | 0.95 | 0.2 | 0.18 | 0.29 | 0.54 | Upgrade
|
| Accrued Expenses | 3.4 | 5.4 | 4.59 | 4.42 | 3.65 | 3.42 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.33 | 4.51 | - | 4.65 | Upgrade
|
| Current Portion of Leases | - | 0.78 | 0.71 | 0.65 | 0.59 | 0.47 | Upgrade
|
| Other Current Liabilities | 0.8 | 0.37 | 1.67 | 1.9 | 0.71 | 2.5 | Upgrade
|
| Total Current Liabilities | 4.4 | 7.5 | 8.51 | 11.66 | 5.23 | 11.58 | Upgrade
|
| Long-Term Debt | - | - | - | - | 4.67 | - | Upgrade
|
| Long-Term Leases | 1.4 | 0.27 | 1.06 | 1.77 | 2.42 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 1.18 | - | Upgrade
|
| Total Liabilities | 5.8 | 7.77 | 9.56 | 13.43 | 13.5 | 11.58 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 638.15 | 635.86 | 534.38 | 516.46 | 509.79 | 453 | Upgrade
|
| Retained Earnings | -569.21 | -559.57 | -513.21 | -483.18 | -454.85 | -427.05 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.05 | - | -0.01 | - | - | Upgrade
|
| Total Common Equity | 69.02 | 76.4 | 21.18 | 33.29 | 54.95 | 26.02 | Upgrade
|
| Shareholders' Equity | 69.03 | 76.41 | 21.19 | 33.29 | 54.96 | 26.03 | Upgrade
|
| Total Liabilities & Equity | 74.83 | 84.18 | 30.75 | 46.72 | 68.45 | 37.6 | Upgrade
|
| Total Debt | 1.4 | 1.06 | 3.1 | 6.93 | 7.68 | 5.13 | Upgrade
|
| Net Cash (Debt) | 63.97 | 74.72 | 20.67 | 32.23 | 52.7 | 25.96 | Upgrade
|
| Net Cash Growth | -32.96% | 261.59% | -35.89% | -38.84% | 103.00% | 41.26% | Upgrade
|
| Net Cash Per Share | 0.97 | 1.33 | 1.09 | 2.11 | 6.15 | 7.42 | Upgrade
|
| Filing Date Shares Outstanding | 69.23 | 66.24 | 65.47 | 16.84 | 14.6 | 7.25 | Upgrade
|
| Total Common Shares Outstanding | 66.28 | 65.5 | 20.22 | 16.84 | 14.6 | 6.74 | Upgrade
|
| Working Capital | 67.3 | 74.85 | 19.67 | 32.42 | 60.01 | 25.15 | Upgrade
|
| Book Value Per Share | 1.04 | 1.17 | 1.05 | 1.98 | 3.76 | 3.86 | Upgrade
|
| Tangible Book Value | 69 | 76.38 | 21.15 | 33.22 | 54.87 | 25.9 | Upgrade
|
| Tangible Book Value Per Share | 1.04 | 1.17 | 1.05 | 1.97 | 3.76 | 3.84 | Upgrade
|
| Machinery | - | 5.41 | 5.07 | 4.84 | 4.48 | 5.25 | Upgrade
|
| Construction In Progress | - | - | 0.13 | - | - | - | Upgrade
|
| Leasehold Improvements | - | 0.12 | 0.12 | 0.12 | 0.12 | 0.08 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.